Explore 3 Stock Ideas & Industry Insights Download Free Report

TAO Synergies Inc.

Company price
2.55 USD -0.03 ( 1.16%)
Last update at 2026-11-11T20:45:00Z
VOLUME
116618
Market Cap
27.43M
P/E
2.36

Momentum Score

…

TAO Synergies Inc. owns and operates an AI token. It focuses on the pure play artificial intelligence (AI) crypto coin, TAO, the native cryptocurrency of Bittensor and a decentralized blockchain network for machine learning and AI. The company was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. TAO Synergies Inc was incorporated in 2012 and is headquartered in New York, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.55
Low
2.76
High
52 Week Price Range
3.06
Low
10.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
2.58
Dividend Yield
-
Revenue TTM
0.77M
Revenue Per Share
0.12
Gross Profit TTM
0.77M
Debt / Equity
-
ROE
-94.45%
Net Debt
-5.50M
ROCE
-37.66%
Diluted EPS TTM
1.55

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -28.74M -12.77M -6.04M -5.57M -12.61M
Net income -28.74M -12.77M -6.04M -5.57M -12.61M
Selling general administrative 9.02M 5.21M 6.34M 9.81M 8.28M
Gross profit 0.30M - - - -
Reconciled depreciation 0.00M 0.01M 0.01M 0.01M 0.00M
Ebit -9.05M -6.81M -8.31M -16.13M -12.62M
Ebitda -9.04M -6.81M -8.31M -16.13M -12.61M
Depreciation and amortization 0.00M 0.01M 0.01M 0.01M 0.00M
Operating income -9.05M -6.81M -8.31M -16.13M -12.62M
Other operating expenses 9.35M 6.81M 8.31M 16.13M 12.62M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.44M 1.28M 1.65M 0.34M 0.01M
Net interest income 0.44M 1.28M 1.65M 0.34M 0.01M
Total revenue 0.30M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 9.35M 6.81M 8.31M 16.13M 12.62M
Total other income expense net -19.69M -5.96M 2.28M 10.56M 0.01M
Net income from continuing ops -28.74M -12.77M -6.04M -5.57M -12.61M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 25.84M 17.73M 31.11M 38.61M 35.52M
Other current assets 19.88M 0.06M 0.43M 1.11M 1.29M
Total liab 3.94M 10.96M 5.53M 3.19M 1.99M
Total stockholder equity 21.90M 6.78M 25.58M 35.41M 33.53M
Other current liab 0.64M 0.70M 3.83M 0.65M 0.70M
Common stock 0.00M 0.00M 0.00M 0.00M 0.00M
Capital stock 0.85M 0.91M 1.24M 2.72M 0.00M
Retained earnings -76.20M -47.17M -33.61M -19.83M -14.14M
Cash 5.50M 17.66M 28.66M 37.48M 34.21M
Total current liabilities 1.81M 1.01M 4.28M 1.31M 1.99M
Net debt -5.50M -17.66M -28.66M -37.48M -34.21M
Other stockholder equity 97.24M 53.03M 57.96M 52.52M 47.67M
Total current assets 25.38M 17.72M 30.53M 38.59M 35.50M
Long term investments 0.45M 0.00M 0.56M 0.00M -
Short term investments - 0.00M 1.44M 0.00M -
Accounts payable 1.18M 0.32M 0.44M 0.66M 1.30M
Accumulated other comprehensive income 0.01M 0.01M 0.00M - -
Non current assets total 0.46M 0.01M 0.58M 0.02M 0.02M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -28.14M -1.00M -2.00M -0.01M -0.00M
Total cashflows from investing activities -28.89M -1.00M -2.00M -0.01M -0.00M
Total cash from financing activities 23.13M -5.12M -1.64M 14.48M 37.13M
Net income -28.74M -12.77M -6.04M -5.57M -12.61M
Change in cash -12.16M -11.01M -8.82M 3.26M 28.42M
Begin period cash flow 17.66M 28.66M 37.48M 34.21M 5.80M
End period cash flow 5.50M 17.66M 28.66M 37.48M 34.21M
Total cash from operating activities -6.40M -4.88M -5.17M -11.21M -8.71M
Issuance of capital stock 14.86M 4.46M 0.00M 13.93M 23.78M
Depreciation 0.00M 0.01M 0.01M 0.01M 0.00M
Dividends paid 0.26M 0.95M 0.64M 0.00M 0.00M
Sale purchase of stock -1.43M -8.63M -1.00M 0.00M -
Other cashflows from financing activities 14.86M -4.17M -1.00M 0.55M 13.35M
Capital expenditures 0.00M 0.00M 0.00M 0.01M 0.00M
Change in working capital 0.42M 0.50M 0.36M -0.61M 0.03M
Stock based compensation 1.39M 0.03M 1.01M 3.74M 3.28M
Other non cash items 20.53M 7.35M -0.51M -8.77M 0.59M
Free cash flow -6.40M -4.88M -5.18M -11.22M -8.71M

Peer Comparison*

Sector: Financial Services Industry: Capital Markets

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TAOX
TAO Synergies Inc.
-0.03
1.16%
2.55 2.36 - 35.50 2.29 40.60 1.28
GS
Goldman Sachs Group Inc
16.62
1.83%
926.81 17.21 16.00 4.47 2.26 11.15 -
SCHW
Charles Schwab Corp
-0.25
0.27%
92.78 19.53 13.89 7.16 4.22 8.80 -
MS
Morgan Stanley
2.95
1.57%
190.51 16.50 13.76 2.80 1.65 - -
IBKR
Interactive Brokers Group Inc
4.90
6.32%
82.49 35.95 27.93 22.14 6.96 3.01 3.37

Profile*

TAO Synergies Inc.

TAO Synergies Inc. owns and operates an AI token. It focuses on the pure play artificial intelligence (AI) crypto coin, TAO, the native cryptocurrency of Bittensor and a decentralized blockchain network for machine learning and AI. The company was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. TAO Synergies Inc was incorporated in 2012 and is headquartered in New York, New York.

1185 Avenue of the Americas, New York, NY, United States, 10036

973 242 0005

4

Name Title Year Born
Mr. Joshua N. Silverman Executive Chairman of the Board 1970
Mr. Robert Weinstein CFO, Executive VP, Treasurer & Secretary 1960
Dr. Alan J. Tuchman M.D., MBA(FAAN) Chief Medical Officer 1947

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…